Support PenkeCorMedix Inc - Trending symbols
Latest News of CorMedix Inc
| Date | Title | Read |
|---|---|---|
| 2025-04-08 13:30 | Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance | Read |
Notifications
| Type | Notification | Date |
|---|---|---|
| RSI Overbought | Overbought RSI (Relative Strength Index) | 2025-05-07 |
Trends
| 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -14,754 | 288 | -14,466 | 315 | -14,151 | 11,375 | -2,777 | 16,241 | 13,464 | |
| Income before Tax | -14,754 | -1,107 | -15,861 | 1,709 | -14,151 | 11,375 | -2,777 | 16,241 | 13,464 | |
| EBIT | -14,754 | -1,097 | -15,851 | 1,706 | -14,145 | 11,378 | -2,767 | 16,241 | 13,474 | |
| EBITDA | -14,701 | -1,093 | -15,794 | 1,762 | -14,032 | 11,380 | -2,652 | 16,298 | 13,646 | |
| Operating Income | -15,669 | -1,035 | -16,704 | 1,403 | -15,301 | 12,013 | -3,287 | 16,223 | 12,936 | |
| Net Income from Continuing Operations | -14,754 | 288 | -14,466 | 315 | -14,151 | 11,375 | -2,777 | 16,241 | 13,464 | |
| Total Stockholder Equity | -195,421 | -22,028 | -217,449 | -28,210 | -245,659 | -29,702 | -275,361 | 345,503 | 70,142 | |
| Liabilities and Stockholders Equity | -189,592 | -22,772 | -212,364 | -27,148 | -239,512 | -28,871 | -268,382 | 350,442 | 82,060 | |
| Other Stockholders Equity | 390,008 | 1,685 | 391,693 | 2,347 | 394,040 | 2,320 | 396,360 | -411,733,520 | -411,337,159 | |
| Other Current Liabilities | 5,138 | 1,832 | 6,970 | -417 | 6,553 | 1,054 | 7,608 | -153,919 | -146,312 | |
| Total Other Income Expense Net | 108 | 72 | 180 | 270 | 450 | 81 | 531 | -560 | -29 | |
| Income Tax Expense | -108 | -72 | -180 | -440,997 | -441,177 | 441,160 | -17 | 31 | 13 | |
| Depreciation and Amortization | 34 | 22 | 56 | 59 | 115 | 69 | 184 | -441,361 | -441,177 | |
| Long-term Assets Other | 102 | 0 | 102 | 0 | 102 | 0 | 102 | -30,302,160 | -30,302,058 | |
| Net non Operating Income Other | 13 | 21 | 35 | 267 | 302 | -278 | 24 | -47 | -23 | |
| Other Current Assets | 1,686 | 71 | 1,757 | -394 | 1,362 | -390 | 972 | -1,021 | -48 | |
| Research Development | 2,294 | 342 | 2,636 | -116 | 2,520 | 2,221 | 4,741 | -7,976 | -3,235 |
Comments
How you think about this?